Sirius XM Holding Inc. (NASDAQ:SIRI) posted its Q4 2024 earnings, revealing a significant earnings per share (EPS) beat, with $0.83 compared to the forecasted $0.08. Despite this, revenue fell ...

Welcome to the SiriusXM fourth-quarter and full-year 2024 operating and financial results conference call. [Operator ...

Morgan Stanley’s stock outpaced gains in other financial stocks Thursday, after the bank and broker forecast a robust flow of deals as it beat both profit and revenue expectations for the latest ...

Sirius XM (NASDAQ:SIRI – Get Free Report) had its target price dropped by equities researchers at Morgan Stanley from $23.00 to $21.00 in a report issued on Thursday,Benzinga reports.

Morgan Stanley analyst Cameron Mansson-Perrone lowered the firm’s price target on Sirius XM (SIRI) to $21 from $23 and keeps an Underweight rating on the shares. Sirius’ FY25 guidance points ...

Star technology banker Michael Grimes is in discussions to leave Morgan Stanley MS0.98%increase; green up pointing triangle to work for the Trump administration, according to people familiar with ...

Palo Alto Networks' (NASDAQ:PANW) recent underperformance has created an attractive entry point for the cybersecurity firm, according to Morgan Stanley. Palo Alto Networks' shares increased 4% by ...

The social media app, which is owned by Meta ... Madison Malone Kircher contributed reporting from New York. Mike Isaac is a technology correspondent for The Times based in San Francisco.

Piers Morgan's show devolved into chaos Thursday after he cut the mic on a guest who bizarrely called him "sweetheart" and "daddy" while repeatedly refusing to answer his questions and dismissed ...

participated in the 43 rd Annual J.P. Morgan Healthcare Conference. During the conference, Dr. De-Chao Michael Yu, Founder, Chairman and CEO of Innovent, delivered a presentation highlighting 2025 as ...

New CEO James Park Delivers First Presentation at J.P. Morgan Healthcare Conference on "Advancing ... proprietary ADC platform featuring a linker technology jointly developed by LOTTE BIOLOGICS ...